The Impact of Alpha Variant (B.1.1.7), Viral Load, and Age on the Clinical Course of Pediatric COVID-19 Patients

Abstract

Objective The research on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mainly consists of adult patients, leaving its impact on children understudied. This study aims to investigate the correlations between viral load, clinical course, age, and Alpha variant (B.1.1.7) in children.

Methods The study was conducted on children under the age of 18 years, who were admitted to Amasya University Sabuncuoglu Serefeddin Research and Training Hospital in Turkey between February and April 2021. ΔCt values, which were obtained by real-time polymerase chain reaction (PCR), were analyzed to estimate the viral loads of the patients. Alpha variant (B.1.1.7) positivity was determined by real-time PCR.

Results There was no difference between estimated viral loads of different clinical courses (p > 0.05), or between asymptomatic and symptomatic patients (p > 0.05). Viral loads were found to decrease with increasing age (p = 0.002). Also, a higher rate of symptomatic disease was found in children under the age of 4 years (p < 0.05). Alpha variant (B.1.1.7) was not found to be associated with severe disease in children (p > 0.05).

Conclusion Our results demonstrate higher viral loads and symptomatic disease in children under the age of 4 years. Alpha variant (B.1.1.7) was not found to be related to disease severity. There has not been a consensus on the vaccination of the pediatric population worldwide. More studies are needed to understand the viral kinetics of SARS-CoV-2 and its severity on children to build effective vaccination strategies in children as public health restrictions are eased.

Keywords

COVID-19 - children - viral load - age - severity - alpha variant (B.1.1.7)

Publikationsverlauf

Eingereicht: 23. Januar 2022

Angenommen: 30. April 2022

Artikel online veröffentlicht:
15. Juli 2022

• References

• 1 Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J 2020; 39 (05) 355-368
• 2 Santos MO, Gonçalves LC, Silva PAN. et al. Multisystem inflammatory syndrome (MIS-C): a systematic review and meta-analysis of clinical characteristics, treatment, and outcomes. J Pediatr (Rio J) 2021; S0021-7557 (21)00148-0
• 3 Marks M, Millat-Martinez P, Ouchi D. et al. Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study. Lancet Infect Dis 2021; 21 (05) 629-636
• 4 Rao SN, Manissero D, Steele VR, Pareja J. A systematic review of the clinical utility of cycle threshold values in the context of COVID-19. Infect Dis Ther 2020; 9 (03) 573-586
• 5 Edward PR, Lorenzo-Redondo R, Reyna ME. et al. Severity of illness caused by severe acute respiratory syndrome coronavirus 2 variants of concern in children: a single-center retrospective cohort study. medRxiv 2021
• 6 Chand M, Hopkins S, Dabrera G. et al. Investigation of Novel SARS-COV-2 Variant: Variant of Concern 202012/01. Public Health England, UK; 2020: 21
• 7 Kuskucu MA, Tok YT, Nohut OK. et al. First report of SARS-CoV-2 gamma variant in Turkey. Infect Dis Clin Microbiol 2021; 3 (02) 97-100
• 8 Oude Munnink BB, Worp N, Nieuwenhuijse DF. et al. The next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology. Nat Med 2021; 27 (09) 1518-1524
• 9 Ministry of Health Turkey. COVID-19 National Guidelines. Accessed May 17, 2022 at: https://covid19saglikgovtr/TR-66342/cocuk-hasta-yonetimi-ve-tedavihtml
• 10 Miranda RL, Guterres A, de Azeredo Lima CH, Filho PN, Gadelha MR. Misinterpretation of viral load in COVID-19 clinical outcomes. Virus Res 2021; 296: 198340
• 11 Aykac K, Cura Yayla BC, Ozsurekci Y. et al. The association of viral load and disease severity in children with COVID-19. J Med Virol 2021; 93 (05) 3077-3083
• 12 World Health Organisation COVID-19 disease in children and adolescents. Available at: WHO/2019-nCoV/Sci_Brief/Children_and_adolescents/20211 2021
• 13 Eastin C, Eastin T. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. J Emerg Med 2020; 58 (04) 712-713
• 14 Armin S, Fahimzad SA, Rafiei Tabatabaei S. et al. COVID-19 mortality in children: a referral center experience from Iran (Mofid Children's Hospital, Tehran, Iran). Can J Infect Dis Med Microbiol 2022; 2022: 2737719
• 15 P MT, Ghosh U, Rajan RJ. et al. Spectrum of COVID-19 disease in children: a retrospective analysis comparing wave 1 and wave 2 from a tertiary hospital in South India. Indian J Pediatr 2022; 1-7
• 16 Albuali WH, AlGhamdi AA, Aldossary SJ. et al. Clinical profile, risk factors and outcomes of ric COVID-19: a retrospective cohort multicentre study in Saudi Arabia. BMJ Open 2022; 12 (03) e053722
• 17 Soebandrio A, Kusumaningrum T, Yudhaputri FA, Oktavianthi S, Malik SG, Myint KSA. Characteristics of children with confirmed SARS-CoV-2 infection in Indonesia. J Clin Virol Plus 2021; 1 (03) 100027
• 18 Fialkowski A, Gernez Y, Arya P, Weinacht KG, Kinane TB, Yonker LM. Insight into the pediatric and adult dichotomy of COVID-19: Age-related differences in the immune response to SARS-CoV-2 infection. Pediatr Pulmonol 2020; 55 (10) 2556-2564
• 19 Costa R, Bueno F, Albert E. et al. Upper respiratory tract SARS-CoV-2 RNA loads in symptomatic and asymptomatic children and adults. Clin Microbiol Infect 2021; 27 (12) 1858.e1-1858.e7
• 20 Kociolek LK, Muller WJ, Yee R. et al. Comparison of upper respiratory viral load distributions in asymptomatic and symptomatic children diagnosed with SARS-CoV-2 infection in pediatric hospital testing programs. J Clin Microbiol 2020; 59 (01) e02593-20
• 21 Bhuiyan MU, Stiboy E, Hassan MZ. et al. Epidemiology of COVID-19 infection in young children under five years: a systematic review and meta-analysis. Vaccine 2021; 39 (04) 667-677
• 22 Ochoa V, Erra Díaz F, Ramirez E. et al. Infants younger than 6 months old infected by SARS-CoV-2 show the highest respiratory viral loads. J Infect Dis 2021
• 23 Zachariah P, Halabi KC, Johnson CL, Whitter S, Sepulveda J, Green DA. Symptomatic infants have higher nasopharyngeal SARS-CoV-2 viral loads but less severe disease than older children. Clin Infect Dis 2020; 71 (16) 2305-2306
• 24 Pinninti SG, Pati S, Poole C. et al. Virological characteristics of hospitalized children with SARS-CoV-2 infection. Pediatrics 2021; 147 (05) e2020037812
• 25 Paul LA, Daneman N, Schwartz KL. et al. Association of age and pediatric household transmission of SARS-CoV-2 infection. JAMA Pediatr 2021; 175 (11) 1151-1158
• 26 Soriano-Arandes A, Gatell A, Serrano P. et al; COVID-19 Pediatric Disease in Catalonia Research Group. Household severe acute respiratory syndrome coronavirus 2 transmission and children: a network prospective study. Clin Infect Dis 2021; 73 (06) e1261-e1269
• 27 Heald-Sargent T, Muller WJ, Zheng X, Rippe J, Patel AB, Kociolek LK. Age-related differences in nasopharyngeal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) levels in patients with mild to moderate coronavirus disease 2019 (COVID-19). JAMA Pediatr 2020; 174 (09) 902-903
• 28 Madera S, Crawford E, Langelier C. et al. Nasopharyngeal SARS-CoV-2 viral loads in young children do not differ significantly from those in older children and adults. Sci Rep 2021; 11 (01) 3044
• 29 Maltezou HC, Magaziotou I, Dedoukou X. et al; for Greek Study Group on SARS-CoV-2 Infections in Children. Children and adolescents with SARS-CoV-2 infection: epidemiology, clinical course and viral loads. Pediatr Infect Dis J 2020; 39 (12) e388-e392
• 30 Rabaan AA, Tirupathi R, Sule AA. et al. Viral dynamics and real-time RT-PCR CT values correlation with disease severity in COVID-19. Diagnostics (Basel) 2021; 11 (06) 1091
• 31 Bullard J, Dust K, Funk D. et al. Predicting infectious severe acute respiratory syndrome coronavirus 2 from diagnostic samples. Clin Infect Dis 2020; 71 (10) 2663-2666
• 32 La Scola B, Le Bideau M, Andreani J. et al. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur J Clin Microbiol Infect Dis 2020; 39 (06) 1059-1061
• 33 Calistri P, Amato L, Puglia I. et al. Infection sustained by lineage B.1.1.7 of SARS-CoV-2 is characterised by longer persistence and higher viral RNA loads in nasopharyngeal swabs. Int J Infect Dis 2021; 105: 753-755
• 34 Frampton D, Rampling T, Cross A. et al. Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study. Lancet Infect Dis 2021; 21 (09) 1246-1256
• 35 Meyer M, Holfter A, Ruebsteck E. et al. The alpha variant (B.1.1.7) of SARS-CoV-2 in children: first experience from 3544 nucleic acid amplification tests in a cohort of children in Germany. Viruses 2021; 13 (08) 1600
• 36 Yoshida M, Worlock KB, Huang N. et al; NU SCRIPT Study Investigators. Local and systemic responses to SARS-CoV-2 infection in children and adults. Nature 2022; 602 (7896): 321-327
• 37 Brookman S, Cook J, Zucherman M, Broughton S, Harman K, Gupta A. Effect of the new SARS-CoV-2 variant B.1.1.7 on children and young people. Lancet Child Adolesc Health 2021; 5 (04) e9-e10
• 38 Han MS, Byun JH, Cho Y, Rim JH. RT-PCR for SARS-CoV-2: quantitative versus qualitative. Lancet Infect Dis 2021; 21 (02) 165
• 39 Centers for Disease Control and Prevention (CDC). COVID-19 Vaccines for Children and Teens. Accessed May 17, 2022 at: https://wwwcdcgov/coronavirus/2019-ncov/vaccines/recommendations/children-teenshtml#:~:text=Teens%20Ages%2012%20and%20Older,younger%20than%2012%20years%20old 2022